Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation (Q34830142)

4 August 2017

title

Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation (English)

1 reference

4 August 2017

1 reference

1 reference

Pneumocystis carinii

1 reference

Marras TK

1

1 reference

4 August 2017

Sanders K

2

1 reference

4 August 2017

Lipton JH

3

1 reference

4 August 2017

Messner HA

4

1 reference

4 August 2017

Conly J

5

1 reference

4 August 2017

Chan CK

6

1 reference

4 August 2017

publication date

1 June 2002

1 reference

Transplant Infectious Disease

4 August 2017

published in

1 reference

4 August 2017

volume

4

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

66-74

1 reference

Pulmonary complications of bone marrow transplantation

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

Deposition of Aerosolized Pentamidine and Failure of Pneumocystis Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

Aerosolized pentamidine as alternative primary prophylaxis against Pneumocystis carinii pneumonia in adult hepatic and renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

Infectious complications of immunosuppressive therapy in patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

Primary Pneumocystis carinii Prophylaxis with Aerosolized Pentamidine after Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

A Controlled Study of Inhaled Pentamidine for Primary Prevention ofPneumocystis cariniiPneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. An Italian multicentric randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

7 January 2021

Alveolar targeting of aerosol pentamidine. Toward a rational delivery system

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

7 January 2021

Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

7 January 2021

Utility of inhaled pentamidine prophylaxis in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

7 January 2021

Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

7 January 2021

The use of aerosolized pentamidine for prophylaxis of Pneumocystis carinii pneumonia in children with leukemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

7 January 2021

Aerosolized pentamidine for the prevention of Pneumocystis carinii pneumonia in children with cancer intolerant or allergic to trimethoprim/sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

7 January 2021

Nebulised pentamidine prophylaxis for Pneumocystis pneumonia in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

7 January 2021

An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-1-00008.X

7 January 2021

10.1034/J.1399-3062.2002.T01-1-00008.X

Identifiers

DOI

1 reference

4 August 2017

1 reference